BlossomHill Therapeutics, Inc.（BLSM）内部人交易：高管与董事近期交易
过去 18 个月，共有 15 位内部人为 BlossomHill Therapeutics, Inc.（BLSM）报告了 39 笔 Form 4 交易（最近一笔 2026-08-12）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-12 | ORBIMED ADVISORS LLC | 董事 | 买入 | 1.0M | $0 |
| 2026-08-12 | GORDON CARL L | 董事 | 买入 | 1.0M | $0 |
| 2026-08-12 | OrbiMed Capital GP VIII LLC | 董事 | 买入 | 1.0M | $0 |
| 2026-08-12 | ORBIMED ADVISORS LLC | 董事 | 买入 | 1.0M | $0 |
| 2026-08-12 | GORDON CARL L | 董事 | 买入 | 1.0M | $0 |
| 2026-08-12 | OrbiMed Capital GP VIII LLC | 董事 | 买入 | 1.0M | $0 |
| 2026-08-12 | ORBIMED ADVISORS LLC | 董事 | 买入 | 625,000 | $10.0M |
| 2026-08-12 | GORDON CARL L | 董事 | 买入 | 625,000 | $10.0M |
| 2026-08-12 | OrbiMed Capital GP VIII LLC | 董事 | 买入 | 625,000 | $10.0M |
| 2026-08-10 | Cormorant Asset Management, LP | 10% 以上股东 | 买入 | 1.6M | $0 |
| 2026-08-10 | Schmid John P. | 董事 | 买入 | 6,000 | $96,000 |
| 2026-08-10 | Chen Bihua | 董事 | 买入 | 1.6M | $0 |
| 2026-08-10 | Cormorant Global Healthcare Master Fund, LP | 10% 以上股东 | 买入 | 1.6M | $0 |
| 2026-08-10 | Keyes Jason A | Chief Financial Officer | 买入 | 700 | $11,200 |
| 2026-08-10 | Li Yishan | Executive Chairman | 买入 | 1.6M | $0 |
| 2026-08-10 | Cui Jingrong Jean | President and CEO | 买入 | 1.6M | $0 |
| 2026-08-10 | Cormorant Private Healthcare Fund III LP | 10% 以上股东 | 买入 | 1.6M | $0 |
| 2026-08-10 | Agrawal Sundeep | 董事 | 买入 | 578,524 | $0 |
| 2026-08-10 | Cormorant Private Healthcare Fund V LP | 10% 以上股东 | 买入 | 1.6M | $0 |
| 2026-08-10 | Cormorant Private Healthcare Fund VI, LP | 10% 以上股东 | 买入 | 1.6M | $0 |
| 2026-08-10 | Liptak Vincent Paul | General Counsel | 买入 | 2,500 | $39,500 |
| 2026-08-10 | Cormorant Asset Management, LP | 10% 以上股东 | 买入 | 1.7M | $0 |
| 2026-08-10 | Chen Bihua | 董事 | 买入 | 1.7M | $0 |
| 2026-08-10 | Cormorant Global Healthcare Master Fund, LP | 10% 以上股东 | 买入 | 1.7M | $0 |
| 2026-08-10 | Li Yishan | Executive Chairman | 买入 | 113,435 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-12